Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,770 | 760 | 96.8% |
| Education | $319.80 | 22 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,036 | 85 | $0 (2021) |
| Novo Nordisk Inc | $836.91 | 68 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $824.43 | 56 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $797.16 | 64 | $0 (2021) |
| PFIZER INC. | $573.01 | 63 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $559.45 | 45 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $529.09 | 49 | $0 (2020) |
| Astellas Pharma US Inc | $509.13 | 21 | $0 (2022) |
| Allergan, Inc. | $474.35 | 55 | $0 (2021) |
| Lilly USA, LLC | $398.88 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.17 | 4 | IDORSIA PHARMACEUTICALS US INC ($36.64) |
| 2023 | $157.17 | 15 | ABBVIE INC. ($156.38) |
| 2022 | $103.92 | 5 | Astellas Pharma US Inc ($50.00) |
| 2021 | $749.71 | 40 | GlaxoSmithKline, LLC. ($133.79) |
| 2020 | $2,286 | 162 | GlaxoSmithKline, LLC. ($262.63) |
| 2019 | $2,264 | 182 | GlaxoSmithKline, LLC. ($241.39) |
| 2018 | $2,086 | 177 | Novo Nordisk Inc ($229.43) |
| 2017 | $2,354 | 197 | AstraZeneca Pharmaceuticals LP ($225.90) |
All Payment Transactions
782 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Insomnia | ||||||
| 06/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Hematology | ||||||
| 03/27/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Insomnia | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 09/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $50.00 | General |
| 08/04/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2022 | Almatica Pharma LLC | GRALISE (Drug), SERTRALINE HCL, LOREEV XR | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: POSTHERPETIC NEURALGIA | ||||||
| 03/25/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,084 | 1,487 | $257,105 | $123,405 |
| 2022 | 10 | 1,127 | 1,571 | $260,453 | $122,675 |
| 2021 | 11 | 1,136 | 1,462 | $214,542 | $102,592 |
| 2020 | 17 | 1,536 | 2,399 | $296,786 | $131,855 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 329 | 689 | $135,733 | $54,029 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 234 | 234 | $46,098 | $29,093 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 135 | $17,955 | $8,246 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 66 | $17,556 | $8,103 | 46.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 110 | 111 | $9,213 | $7,899 | 85.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 34 | 37 | $10,730 | $5,796 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 114 | 115 | $4,600 | $3,387 | 73.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $5,460 | $3,380 | 61.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,700 | $1,978 | 34.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 19 | $2,166 | $765.70 | 35.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $480.00 | $353.40 | 73.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 28 | $1,260 | $256.22 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 14 | $154.00 | $117.60 | 76.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 320 | 680 | $133,960 | $50,724 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 264 | 264 | $52,008 | $33,065 | 63.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 181 | $24,073 | $10,072 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 80 | $21,280 | $9,931 | 46.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 128 | 132 | $10,716 | $8,887 | 82.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 30 | 34 | $9,860 | $5,257 | 53.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 131 | 135 | $5,400 | $3,795 | 70.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 15 | $1,620 | $573.10 | 35.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 29 | $1,305 | $309.52 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 21 | $231.00 | $62.46 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 344 | 569 | $105,031 | $51,994 | 49.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 225 | 246 | $54,723 | $21,482 | 39.3% |
About Dr. Peter Kouvatsos, DO
Dr. Peter Kouvatsos, DO is a Internal Medicine healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053570531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Kouvatsos, DO has received a total of $10,090 in payments from pharmaceutical and medical device companies, with $89.17 received in 2024. These payments were reported across 782 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($9,770).
As a Medicare-enrolled provider, Kouvatsos has provided services to 4,883 Medicare beneficiaries, totaling 6,919 services with total Medicare billing of $480,527. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location York, PA
- Active Since 06/09/2008
- Last Updated 06/27/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053570531
Products in Payments
- FARXIGA (Drug) $500.37
- JARDIANCE (Drug) $446.76
- XIFAXAN (Drug) $383.70
- TRELEGY ELLIPTA (Drug) $368.96
- XARELTO (Drug) $366.71
- CHANTIX (Drug) $360.92
- Ozempic (Drug) $318.47
- Vascepa (Drug) $317.06
- TOUJEO (Drug) $295.28
- MYRBETRIQ (Drug) $249.05
- ENTRESTO (Drug) $235.81
- ANORO (Drug) $207.32
- ANORO ELLIPTA (Drug) $197.17
- Tresiba (Drug) $188.39
- TRULICITY (Drug) $178.22
- Aimovig (Biological) $172.37
- Trintellix (Drug) $169.68
- UBRELVY (Drug) $166.45
- SYMBICORT (Drug) $163.19
- INVOKANA (Drug) $162.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in York
Nader Zaki, M.d, M.D
Internal Medicine — Payments: $420,610
Dr. Christopher Wenger, D.o, D.O
Internal Medicine — Payments: $262,050
Dr. Rodger Stitt, M.d, M.D
Internal Medicine — Payments: $14,593
Ivan Marchena- Mendez, M.d, M.D
Internal Medicine — Payments: $12,136
Dr. Nishi Patel, M.d, M.D
Internal Medicine — Payments: $11,501
Thomas Kurland, Do, DO
Internal Medicine — Payments: $9,665